Latest DEF 14A proxy statements

NASDAQ
Kala Bio, Inc. filed a supplement to its 2025 Proxy Statement, detailing new related party share issuances and an updated count of outstanding common stock.
NASDAQ
Origin Materials, Inc. will hold a Special Meeting on February 17, 2026, to vote on a reverse stock split to maintain Nasdaq listing and the issuance of shares for up to $100 million in convertible notes.
NASDAQ
Adial Pharmaceuticals, Inc. will hold a special meeting on February 26, 2026, to seek stockholder approval for the issuance of up to 13,823,512 shares of common stock related to Series F warrant exercises.
NASDAQ
Twist Bioscience Corporation announces robust fiscal year 2025 financial performance, including record revenue and improved gross margin, ahead of its 2026 Annual Meeting of Stockholders.
AMEX
Theriva Biologics, Inc. is calling a Special Meeting of Stockholders on February 11, 2026, to approve the issuance of up to 16,184,560 common shares from warrant exercises and an adjournment proposal.
OTC.Pink
California First Leasing Corporation seeks shareholder approval for a 1-for-50 reverse stock split to reduce shareholder count and deregister under the Investment Company Act of 1940.
OTC.Pink
Sonida Senior Living will acquire CNL Healthcare Properties in a cash and stock transaction valued at approximately $1.8 billion, creating the eighth largest U.S. senior living owner.
NYSE
Templeton Emerging Markets Fund announces its 2026 Annual Meeting of Shareholders to vote on the election of four Trustees and the ratification of PricewaterhouseCoopers LLP as its independent auditor.
NASDAQ
Powell Industries, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on February 18, 2026, to elect directors and vote on executive compensation.
Denny's Corporation has filed a supplement to its definitive proxy statement regarding its merger with Sparkle Topco Corp. in response to shareholder lawsuits alleging misleading disclosures.
Crawford United Corporation shareholders are set to vote on a definitive merger agreement with SPX Enterprises, LLC, valuing the company at an estimated $300 million, or $83.42 per share in cash.
NYSE
Apartment Investment and Management Company (Aimco) has filed a definitive proxy statement for a special stockholder meeting to approve its Plan of Sale and Liquidation, aiming to maximize shareholder value.
NASDAQ
Society Pass Incorporated's majority stockholders approved a new 2026 Equity Incentive Plan and the issuance of 2,272,727 common shares to recognize contributions to the NusaTrip IPO.
Synchronoss Technologies, Inc. announces its agreement to be acquired by Lumine Group, outlining 2025 achievements and 2026 strategic priorities.
NYSE
Enviri Corporation announces CFO Tom Vadaketh's retirement, the appointment of Pete Minan as CFO for New Enviri, and confirms the Clean Earth sale and spin-off are on track for mid-2026.
NASDAQ
Keen Vision Acquisition Corporation is seeking shareholder approval to extend its business combination deadline to July 27, 2026, to avoid liquidation.
Synchronoss Technologies, Inc. stockholders are invited to a special meeting on February 12, 2026, to vote on a proposed all-cash merger with Lumine Group US Holdco Inc. at $9.00 per share, representing a 70% premium.
NYSE
Apartment Investment and Management Company (Aimco) seeks stockholder approval for a Plan of Sale and Liquidation, targeting total distributions of $8.58 to $9.93 per share, including prior special dividends.
ON24, Inc. announced a definitive agreement to be acquired by Cvent Atlanta, LLC for $8.10 per share in cash, with the transaction expected to close in the first half of 2026.
NYSE
Bitmine Immersion Technologies, Inc. urges shareholders to vote FOR a proposal to increase authorized shares from 500 million to 50 billion to enable capital market activities, opportunistic deals, and future stock splits.
NASDAQ
J&J Snack Foods Corp. has filed definitive additional proxy materials with the SEC.
NASDAQ
J&J Snack Foods Corp. announces its 2026 Annual Meeting of Shareholders to address director election, auditor ratification, and executive compensation, following a challenging but strategically active fiscal year 2025.
Iterum Therapeutics plc calls an Extraordinary General Meeting to approve critical proposals for capital raising and Nasdaq compliance, warning of potential bankruptcy if not approved.
OQX
Medinotec, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on January 20, 2026, to elect five directors and approve its independent auditor.
AMEX
Azitra, Inc. urges stockholders to approve a share issuance exceeding 19.99% to Alumni Capital LP, crucial for securing an additional $1.5 million in funding and avoiding severe operational risks.
NASDAQ
Rallybio Corporation seeks stockholder approval for a reverse stock split to maintain its Nasdaq listing and enhance stock marketability.
OQB
SideChannel, Inc. announces its Annual Meeting of Stockholders to vote on director elections, a reverse stock split for potential uplisting, and auditor ratification, alongside reporting improved financial performance.
NASDAQ
Moleculin Biotech, Inc. calls a Special Meeting to approve the issuance of up to 2.61 million shares from warrant exercises and a corporate name change to Moleculin Inc.
NYSE
Bitmine Immersion Technologies proposes a massive increase in authorized shares to facilitate future capital activities and accommodate anticipated stock splits driven by Ethereum's projected price surge.
NASDAQ
Cerence Inc. has filed its definitive proxy statement with the SEC, signaling an upcoming shareholder meeting.